Abstract
Purpose
Head and neck cancer (HNC) patients are typically treated with radiotherapy (RT), which might lead to side effects and deterioration of quality of life (QoL). Studies in other cancers indicate that systematic use of patient-reported outcome (PRO) can be a tool to increase awareness of patients’ symptoms and improve QoL. Multiple PRO questionnaires have been developed and validated for HNC, complicating the interpretation of results from scientific studies. In this exploratory study, symptom scores from four essential symptoms present in four different HNC-specific PRO questionnaires were evaluated.
Methods
Four HNC-specific PRO questionnaires (EORTC QLQ-H&N35, FACT-H&N, MDASI-HN, and PRO-CTCAE) for patients undergoing radiotherapy were completed by eligible HNC patients up to ten times during and after RT. Four essential symptoms (pain, dysphagia, hoarseness, and dry mouth) were present in all questionnaires. The symptom scores for these symptoms were aligned and evaluated.
Results
Twelve patients were included and completed a total of 328 PRO questionnaires out of 420. Similarity between symptom score for the four symptoms was found, when the symptom scores were aligned. The symptom scores increased during RT and decreased afterwards for all four symptoms and in all four questionnaires.
Conclusion
Four HNC-specific PRO questionnaires are found similar in reflecting symptom scores over time concerning four important HNC symptoms (pain, dysphagia, hoarseness, and dry mouth). PRO can contribute with targetable information about symptoms, and PRO questionnaires might be a valuable add on to clinical practice enabling a varied picture of patients’ symptoms during radiotherapy.
Availability of data and materials
Not applicable.
Code availability
Not applicable.
Abbreviations
- HNC:
-
Head and neck cancer
- RT:
-
Radiotherapy
- QoL:
-
Quality of life
- DAHANCA:
-
Danish Head and Neck Cancer Group
- PRO:
-
Patient-reported outcome
- EORTC QLQ-H&N35:
-
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Head and Neck Cancer module
- FACT-H&N:
-
Functional Assessment of Cancer Therapy General and Head and Neck
- MDASI-HN:
-
M.D. Anderson Symptom Inventory Head and Neck questionnaire
- PRO-CTCAE:
-
Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events with site-specific Head and Neck item
References
Lo Nigro C, Denaro N, Merlotti A, Merlano M (2017) Head and neck cancer: improving outcomes with a multidisciplinary approach. Cancer Manage Res. https://doi.org/10.2147/CMAR.S115761
Dirix P, Nuyts S, van den Bogaert W (2006) Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer. https://doi.org/10.1002/cncr.22302
Marta GN, Silva V, de Andrade CH, de Arruda FF, Hanna SA, Gadia R et al (2014) Intensity-modulated radiation therapy for head and neck cancer: Systematic review and meta-analysis. Radiother Oncol. https://doi.org/10.1016/j.radonc.2013.11.010
Hamilton SN, Tran E, Ho C, Berthelet E, Wu J, DeVries K et al (2020) Patient-reported outcome measures in patients undergoing radiotherapy for head and neck cancer. Support Care Cancer. https://doi.org/10.1007/s00520-020-05778-2
Rosenthal DI, Mendoza TR, Fuller CD, Hutcheson KA, Wang XS, Hanna EY et al (2014) Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer. https://doi.org/10.1002/cncr.28672
van der Laan HP, van den Bosch L, Schuit E, Steenbakkers RJHM, van der Schaaf A, Langendijk JA (2021) Impact of radiation-induced toxicities on quality of life of patients treated for head and neck cancer. Radiother Oncol. https://doi.org/10.1016/j.radonc.2021.04.011
Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V et al (2003) CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. https://doi.org/10.1016/S1053-4296(03)00031-6
Jensen K, Bonde Jensen A, Grau C (2006) The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires. Radiother Oncol. https://doi.org/10.1016/j.radonc.2006.02.005
Laugsand EA, Sprangers MAG, Bjordal K, Skorpen F, Kaasa S, Klepstad P (2010) Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health Qual Life Outcomes. https://doi.org/10.1186/1477-7525-8-104
Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C et al (2017) Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. https://doi.org/10.1001/jama.2017.7156
Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P et al (2016) Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. https://doi.org/10.1200/JCO.2015.63.0830
Kotronoulas G, Kearney N, Maguire R, Harrow A, di Domenico D, Croy S et al (2014) What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol. https://doi.org/10.1200/JCO.2013.53.5948
Velikova G, Booth L, Smith AB, Brown PM, Lynch P, Brown JM et al (2004) Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol. https://doi.org/10.1200/JCO.2004.06.078
Chera BS, Eisbruch A, Murphy BA, Ridge JA, Gavin P, Reeve BB et al (2014) Recommended patient-reported core set of symptoms to measure in head and neck cancer treatment trials. J Nat Cancer Inst. https://doi.org/10.1093/jnci/dju127
Ojo B, Genden EM, Teng MS, Milbury K, Misiukiewicz KJ, Badr H (2012) A systematic review of head and neck cancer quality of life assessment instruments. Oral Oncol. https://doi.org/10.1016/j.oraloncology.2012.03.025
Bjordal K, Hammerlid E, Ahlner-Elmqvist M, de Graeff A, Boysen M, Evensen JF et al (1999) Quality of life in head and neck cancer patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H and N35. J Clin Oncol. https://doi.org/10.1200/jco.1999.17.3.1008
Holländer-Mieritz C, Johansen J, Johansen C, Vogelius IR, Kristensen CA, Pappot H (2019) Comparing the patients’ subjective experiences of acute side effects during radiotherapy for head and neck cancer with four different patient-reported outcomes questionnaires. Acta Oncol. https://doi.org/10.1080/0284186X.2018.1563713
D’Antonio LL, Zimmerman GJ, Cella DF, Long SA (1996) Quality of life and functional status measures in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. https://doi.org/10.1001/archotol.1996.01890170018005
Rosenthal DI, Mendoza TR, Chambers MS, Asper JA, Gning I, Kies MS et al (2007) Measuring head and neck cancer symptom burden: the development and validation of the M.D. Anderson symptom inventory, head and neck module. Head Neck. https://doi.org/10.1002/hed.20602
Sandler KA, Mitchell SA, Basch E, Raldow AC, Steinberg ML, Sharif J et al (2018) Content validity of anatomic site-specific patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) item sets for assessment of acute symptomatic toxicities in radiation oncology. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/j.ijrobp.2018.04.048
van den Bosch L, van der Laan HP, van der Schaaf A, Oosting SF, Halmos GB, Witjes MJH et al (2021) Patient-reported toxicity and quality of life profiles in head and neck cancer patients treated with definitive radiotherapy or chemoradiation. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/j.ijrobp.2021.05.114
Bentzen SM, Rosenthal DI, Weymuller EA, Trotti A (2007) Increasing toxicity in nonoperative head and neck cancer treatment: investigations and interventions. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/j.ijrobp.2007.04.080
Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. https://doi.org/10.1200/JCO.2007.14.8841
Taarnhøj GA, Kennedy FR, Absolom KL, Bæksted C, Vogelius IR, Johansen C et al (2018) Comparison of EORTC QLQ-C30 and PRO-CTCAETM Questionnaires on six symptom items. J Pain Symp Manage. https://doi.org/10.1016/j.jpainsymman.2018.05.017
Tschiesner U, Rogers SN, Harréus U, Berghaus A, Cieza A (2008) Content comparison of quality of life questionnaires used in head and neck cancer based on the international classification of functioning, disability and health: a systematic review. Eur Arch Oto-Rhino-Laryngol. https://doi.org/10.1007/s00405-008-0641-9
Jensen J, Hansen CF, Brodersen J, Comins JD, Krogsgaard MR (2020) Are PROMs used adequately in sports research? An analysis of 54 randomized controlled trials with PROMs as endpoint. Scand J Med Sci Sports. https://doi.org/10.1111/sms.13880
Jensen K, Lambertsen K, Torkov P, Dahl M, Jensen AB, Grau C (2007) Patient assessed symptoms are poor predictors of objective findings. Results from a cross sectional study in patients treated with radiotherapy for pharyngeal cancer. Acta Oncol. https://doi.org/10.1080/02841860701491041
Holländer-Mieritz C, Johansen J, Taarnhøj GA, Johansen C, Vogelius IR, Kristensen CA et al (2020) Systematic use of patient reported outcome during radiotherapy for head and neck cancer: study protocol for the national DAHANCA 38 trial. Acta Oncol. https://doi.org/10.1080/0284186X.2020.1725244
Funding
The study was unfunded.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by EBS-O, CH-M, HP and DRS. The first draft of the manuscript was written by EBS-O and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Ethical approval
The study received approval by the Danish Data Protection Agency (File number, VD-2018-300, I-Suite no. 6544). The study complied with all aspects of ethical standards of clinical research.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Steen-Olsen, E.B., Stormoen, D.R., Kristensen, C.A. et al. Patient-reported outcome during radiotherapy for head and neck cancer: the use of different PRO questionnaires. Eur Arch Otorhinolaryngol 279, 4199–4206 (2022). https://doi.org/10.1007/s00405-022-07364-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-022-07364-0